# Lefamulin Post-Market Surveillance Study

> **NCT07697885** · — · RECRUITING · sponsor: **Marubeni Pharmaceuticals (Suzhou) Co., Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Community-Acquired Pneumonia (CAP)

## Interventions

- **OTHER:** This is a multicenter, single-arm, non-interventional study. No interventional measures will be adopted.

## Key facts

- **NCT ID:** NCT07697885
- **Lead sponsor:** Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697885, "Lefamulin Post-Market Surveillance Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*